Award recognizes Glooko’s software portfolio supporting diabetes and glycemic management across outpatient care, inpatient glycemic management, regional remote monitoring, and patient self-management ...
Three-year analysis shows a 98% reduction in severe hypoglycemia, low severe hyperglycemia, and comparable safety in severe renal impairment. Glooko, Inc., a globally integrated digital healthcare ...
Glooko is looking to expand its diabetes treatment platforms to the inpatient setting, with a plan to acquire Monarch Medical Technologies and its EndoTool software for managing insulin doses within ...
PALO ALTO, Calif., September 23, 2025--(BUSINESS WIRE)--Glooko, Inc., a leading provider of remote patient monitoring and digital health solutions for diabetes, today announced that it has acquired ...
Artificial intelligence is helping Temple Health prevent patients with diabetes from experiencing dangerous swings in their ...
CHARLOTTE, N.C., June 20 - MD Scientific, LLC (MD Scientific), announces Food and Drug Administration clearance to market EndoTool(TM) Glucose Management System. EndoTool(TM) is an intravenous insulin ...
KENNESAW, Ga.--(BUSINESS WIRE)--Aug. 7, 2006--Advocos LLC, a contract sales organization which provides sales and marketing services to the pharmaceutical, bio-tech and medical device industries, ...
Glooko, Inc., a global digital health company focused on helping clinicians address the growing challenges of diabetes management and glycemic safety across the care continuum, today announced it has ...
Award recognizes Glooko’s software portfolio supporting diabetes and glycemic management across outpatient care, inpatient glycemic management, regional remote monitoring, and patient self-management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results